Literature DB >> 35045259

A Molecular Networking Based Discovery of Diketopiperazine Heterodimers and Aspergillicins from Aspergillus caelatus.

Xinhui Wang1, Rachel Serrano2, Victor González-Menéndez2, Thomas A Mackenzie2, Maria C Ramos2, Jens C Frisvad1, Thomas O Larsen1.   

Abstract

The number of species in Aspergillus section Flavi has recently increased to 36 and includes some of the most important and well-known species in the genus Aspergillus. Numerous secondary metabolites, especially mycotoxins, have been reported from species such as A. flavus; however many of the more recently described species are less studied from a chemical point of view. This paper describes the use of MS/MS-based molecular networking to investigate the metabolome of A. caelatus leading to the discovery of several new diketopiperazine dimers and aspergillicins. An MS-guided isolation procedure yielded six new compounds, including asperazines D-H (1-5) and aspergillicin H (6). Asperazines G and H are artifacts derived from asperazines E and F formed during the separation process by formic acid. Two known compounds, aspergillicins A and C (7 and 8), were isolated from the same strain. Structures were elucidated by analyzing their HR-MS/MS and NMR spectroscopic data. The absolute configuration of asperazines D-F and aspergillicin H were deduced from the combination of NMR, Marfey's method, and ECD analyses.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35045259     DOI: 10.1021/acs.jnatprod.1c00526

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  2 in total

1.  An integrated strategy for the comprehensive profiling of the chemical constituents of Aspongopus chinensis using UPLC-QTOF-MS combined with molecular networking.

Authors:  Fengyu Zhang; Bichen Li; Ying Wen; Yanyang Liu; Rong Liu; Jing Liu; Shao Liu; Yueping Jiang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  Kribbellichelins A and B, Two New Antibiotics from Kribbella sp. CA-293567 with Activity against Several Human Pathogens.

Authors:  Jorge R Virués-Segovia; Fernando Reyes; Sandra Ruíz; Jesús Martín; Ignacio Fernández-Pastor; Carlos Justicia; Mercedes de la Cruz; Caridad Díaz; Thomas A Mackenzie; Olga Genilloud; Ignacio González; José R Tormo
Journal:  Molecules       Date:  2022-09-26       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.